Age cut-off for the loss of benefit from bilateral internal thoracic artery grafting

Eur J Cardiothorac Surg. 2008 Jun;33(6):977-82. doi: 10.1016/j.ejcts.2008.03.026. Epub 2008 Apr 29.

Abstract

Objectives: To identify the age-related benefit of single and bilateral internal thoracic artery (ITA) grafting on long-term cardiac-related survival in patients who survived from primary isolated coronary artery bypass grafting (CABG).

Methods: A unicenter study was conducted on 12,231 consecutive survivors from primary isolated CABG who received single (n=9566 patients) or bilateral (n=1388 patients) ITA grafts, or vein grafts only (n=1277 patients) between 1992 and 2005. Data was collected prospectively. The Cox regression model estimates the hazard ratio of each independent variable on cardiac-specific survival over the entire length of follow-up. Age was a significant covariate into the statistical model. The mean follow-up was 5.7+/-3.7 years and 100% complete as of December 2005. The date and cause of death were obtained from the regional statistical institute.

Results: After adjustments for different risk factors, the cardiac-related survival benefit in patients undergoing CABG with two ITAs was superior to that of single ITA grafting up to 60 years of age, displaying a constant decrease over time. The use of a single ITA was beneficial on cardiac-related survival in all age groups, including octogenarians, compared to patients receiving only vein grafts.

Conclusions: The use of at least one ITA is associated with increased long-term cardiac-specific survival in all age groups compared to venous-only CABG, even in octogenarians. The additional survival benefit of using a second ITA decreases gradually with age, and is lost after 60 years of age.

MeSH terms

  • Adult
  • Age Factors*
  • Aged
  • Aged, 80 and over
  • Epidemiologic Methods
  • Female
  • Humans
  • Internal Mammary-Coronary Artery Anastomosis / methods
  • Internal Mammary-Coronary Artery Anastomosis / mortality*
  • Male
  • Middle Aged
  • Prognosis
  • Quebec / epidemiology
  • Treatment Outcome